By Wendy Van Sickle
Columbus, Ohio, Feb. 13 – UBS AG, London Branch priced $11 million of phoenix autocallable buffer notes with memory interest due Feb. 13, 2025 linked to SPDR S&P Biotech ETF shares, according to a 424B2 filing with the Securities and Exchange Commission.
If the ETF closes at or above the coupon barrier level, 80% of the initial level, on a monthly observation date, the notes will pay a contingent coupon for that month at an annualized rate of 14.00004%, plus any previously unpaid contingent coupon payments.
The notes will be called at par if the shares close at or above the initial share price on any observation date other than the final date.
The payout at maturity will be par unless the ETF finishes below the buffer level, in which case investors will lose 1.25% for every 1% that the ETF declines beyond 20%.
UBS Investment Bank is the underwriter. JPMorgan Chase Bank, NA and J.P. Morgan Securities LLC are the agents.
| Issuer: | UBS AG, London Branch
|
| Issue: | Phoenix autocallable buffer notes with memory interest
|
| Underlying ETF: | SPDR S&P Biotech ETF
|
| Amount: | $11 million
|
| Maturity: | Feb. 13, 2025
|
| Coupon: | 14.00004% annualized, plus any previously unpaid coupons, if ETF closes at or above coupon barrier level on monthly observation date
|
| Price: | Par
|
| Payout at maturity: | Par if ETF finishes at or above buffer level; otherwise, 1.25% loss for every 1% that ETF declines beyond 20%
|
| Call: | At par if ETF closes at or above initial level on a monthly observation date
|
| Initial price: | $878.07
|
| Coupon barrier: | $70.46, 80% of initial price
|
| Buffer level: | $70.46, 80% of initial price
|
| Strike date: | Feb. 7
|
| Pricing date: | Feb. 8
|
| Settlement date: | Feb. 13
|
| Underwriter: | UBS Investment Bank
|
| Placement agents: | JPMorgan Chase Bank, NA and J.P. Morgan Securities LLC
|
| Fees: | 0.1%
|
| Cusip: | 90279WY99
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
